Alan B. Sandler
Chief Development Officer · Revolution Medicines, Inc.
- 2024
- Oct 1, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Alan B. Sandler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Margaret A. Horn - $25.81M in RVMD purchases and sales in the last 12 months
- Stephen Michael Kelsey - $21.33M in RVMD purchases and sales in the last 12 months
- Jeff Cislini - $15.27M in RVMD purchases and sales in the last 12 months
- Lorence H. Kim - $14.97M in RVMD purchases and sales in the last 12 months
- Anthony Mancini - $9.79M in RVMD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alan B. Sandler?
Alan B. Sandler is a corporate insider, tracked as Chief Development Officer of Revolution Medicines, Inc. (RVMD). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alan B. Sandler submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Alan B. Sandler been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.34M) across all tracked filings.
